思埃然完成超亿元融资，千骥资本、顺为资本联合领投

Core Insights - Honghui Fund's portfolio company, Siairan, has completed over 100 million yuan financing, led by Qianji Capital and Shunwei Capital, with existing investors including Boxin Capital and Honghui Fund increasing their stakes [1] - The funds will primarily be used for the in-depth research and development of the company's first self-developed phacoemulsification and vitrectomy integrated machine, as well as to expand the product matrix of ophthalmic surgical equipment [1] - Siairan Medical, established in July 2022, has a core team with extensive industry experience and complete capabilities in R&D, production, and commercialization [1] Company Overview - Siairan Medical focuses on providing precise and intelligent minimally invasive surgical solutions for ophthalmology, aiming to break the monopoly of foreign companies in the high-end ophthalmic surgical instrument sector [1] - The company is addressing critical issues related to key surgical instruments and is currently developing products including the phacoemulsification and vitrectomy integrated machine and digital surgical microscopes [1] - Siairan Medical is committed to offering innovative and high-quality products and services to ophthalmologists and patients, promoting the advancement of ophthalmic medical technology [1]